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Abstract. 
 
Abnormal proteins, which escape chaperone-
mediated refolding or proteasome-dependent degrada-
tion, aggregate and form inclusion bodies (IBs). In several
neurodegenerative diseases, such IBs can be formed by
proteins with expanded polyglutamine (polyQ) domains
(e.g., huntingtin). This work studies the regulation of in-
 
tracellular IB formation using an NH
 
2
 
-terminal frag-
ment of huntingtin with expanded polyQ domain. We
demonstrate that the active form of MEKK1, a protein
kinase that regulates several stress-activated signaling
 
cascades, stimulates
 
 
 
formation of the IBs. This function
of MEKK1 requires kinase activity, as the kinase-dead
 
mutant of MEKK1 cannot stimulate this process. Expo-
sure of cells to UV irradiation or cisplatin, both of
which activate MEKK1, also augmented the formation
of IBs. The polyQ-containing huntingtin fragment exists
in cells in two distinct forms: (a) in a discrete soluble
complex, and (b) in association with insoluble fraction.
MEKK1 strongly stimulated recruitment of polyQ
polypeptides into the particulate fraction. Notably, a
large portion of the active form of MEKK1 was associ-
ated with the insoluble fraction, concentrating in dis-
crete sites, and polyQ-containing IBs always colocalized
with them. We suggest that MEKK1 is involved in a
process of IB nucleation. MEKK1 also stimulated for-
mation of IBs with two abnormal polypeptides lacking
the polyQ domain, indicating that this kinase has a gen-
eral effect on protein aggregation.
Key words: protein aggregation • inclusion body •
polyglutamine • MEKK1 • stress
 
Introduction
 
Abnormal polypeptides often emerge in mammalian cells
as a result of denaturation due to stressful environments,
chemical modifications, or mutations. Normally, cells can
cope with accumulation of damaged proteins by either re-
folding them in chaperone-dependent processes or degrad-
ing them via the ubiquitin–proteasome system. However, if
the cell’s ability to refold or degrade abnormal polypep-
tides is exceeded, the denatured or partially unfolded mol-
ecules tend to aggregate (Dubois et al., 1991; Gragerov et
al., 1991; Cotner and Pious, 1995; Kampinga et al., 1995;
Johnston et al., 1998; Wigley et al., 1999) and form large in-
clusion bodies (IBs)
 
1
 
 (Prouty et al., 1975; Klemes et al.,
1981; Gragerov et al., 1991; Rinas and Bailey, 1993). It was
initially assumed that these IBs result simply from the in-
trinsic ability of denatured proteins to associate with each
other until the aggregates become insoluble. However, re-
cent findings indicate that IB formation in mammalian cells
is a complex process that may actively involve cellular com-
ponents. In the cytoplasm, proteins form small aggregates
that are then transported along the microtubules into the
centrosome (Johnston et al., 1998; Anton et al., 1999; Gar-
cia-Mata et al., 1999; Vidair et al., 1999; Wigley et al., 1999;
Fabunmi et al., 2000). Resulting IBs also incorporate heat
shock proteins, ubiquitin, ubiquitin-conjugating enzymes,
and 26S proteasomes (Wojcik et al., 1996; Anton et al.,
1999; Garcia-Mata et al., 1999; Vidair et al., 1999; Wigley et
al., 1999; Fabunmi et al., 2000), forming a large structure
recently termed the “aggresome” (Johnston et al., 1998).
In a wide variety of hereditary diseases, abnormal
polypeptides, which play a critical role in pathogenesis, ac-
cumulate in cells in a form of insoluble IBs. Neurological
diseases associated with appearance of IBs in neurons in-
clude Alzheimer’s disease, Parkinson’s disease, and Hun-
tington’s disease, among others. IBs formed by different
abnormal proteins in the course of such diseases have
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2
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many common features, including recruitment of compo-
nents of the ubiquitin–proteasome-dependent degradation
pathway and molecular chaperones, which suggests that
such IBs may be similar to the aggresome.
Several diseases, including Huntington’s disease (Bao et
al., 1996; Gusella and Macdonald, 1998) and spinocerebel-
lar ataxias (Cummings et al., 1999a), are associated with
accumulation of abnormal proteins containing a poly-
glutamine (polyQ) domain. Expansion of such polyQ do-
main beyond the normal length results in abnormal pro-
tein conformation, which leads to aggregation as well as
sequestration of various cell proteins (Bates et al., 1998).
In the case of huntingtin, its proteolytic cleavage is an im-
portant factor promoting aggregation in
 
 
 
neurons (Gold-
berg et al., 1996; Difiglia et al., 1997; Kahlem et al., 1998a;
Wellington et al., 1998). Smaller polyQ-containing frag-
ments of 350- kD huntingtin are more prone to aggregate,
they easily form 
 
b
 
 sheets (Perutz, 1999), and may be cross-
linked by transglutaminase (Kahlem et al., 1996, 1998a,b).
The formation of IBs generally precedes neuronal death,
which has led to the suggestion that formation of the ag-
gregates may trigger neuropathology. On the other hand,
there is much evidence that aggregation of polyQ-contain-
ing polypeptides does not contribute to pathogenesis (Kle-
ment et al., 1998; Saudou et al., 1998; Cummings et al.,
1999b). Therefore, it is possible that the soluble pools of
abnormal huntingtin molecules are deleterious to the cell,
and that aggregate formation may be protective by reduc-
ing the level of the abnormal proteins in a soluble phase.
In several models, expression of polyQ-containing poly-
peptides has been shown to cause cellular stress responses
(Chai et al., 1999; Stenoien et al., 1999). Such a response
involves induction of heat shock proteins, which were re-
ported to be induced in cells expressing polyQ (Cummings
et al., 1998; Chai et al., 1999), and to protect from polyQ-
induced neurodegeneration in a mouse model (Cummings,
C.J., and H.Y. Zoghbi, personal communication), as well as
from apoptosis in 
 
Drosophila
 
 (Kazemi-Esfarjani and Ben-
zer, 2000). Another component of the stress response is acti-
vation of stress kinases, which may initiate an apoptotic pro-
gram (Gabai et al., 1998). PolyQ expression was shown in
cell culture to activate the stress kinase c-Jun NH
 
2
 
-terminal
kinase (JNK), which appears to be essential for apoptosis
triggered by such expression (Liu, 1998; Yasuda et al., 1999).
Thus, cells accumulating polypeptides with expanded polyQ
sequences appear to be constantly exposed to internal
“stress,” and respond to it by activation of a protective
mechanism and/or initiation of the apoptotic program.
Regardless of whether protein aggregation is a protec-
tive or a proapoptotic cellular event, it is conceivable that
formation of IBs in a cell may be regulated under stressful
conditions caused by accumulation of abnormal proteins.
One attractive possibility is that IB formation is stimulated
by the stress-activated signaling cascade. To test this idea,
we focused on a protein kinase, mitogen-activated protein
kinase (MAPK) kinase kinase (MEKK)1, which is acti-
vated by various stressful treatments (e.g., UV irradiation,
DNA-damaging agents, cytokines), and regulates stress-
induced MAPK signaling pathways, including JNK, extra-
cellular signal–regulated kinase (ERK), p38, and NF-
 
k
 
B
(Kyriakis and Avruch, 1996). MEKK1 is a 196-kD serine-
threonine kinase that can associate with, and be activated
 
by, small GTP-binding proteins (Collins et al., 1996).
MEKK1 can also be activated by a caspase-mediated
cleavage, resulting in an active 91-kD fragment (Widmann
et al., 1998). In this work we studied the effects of MEKK1
on the formation of IBs by polyQ-containing polypeptides
and other abnormal proteins.
 
Materials and Methods
 
Plasmids and Antibodies
 
DNA constructs for expression of huntingtin, with alternating CAG/CAA
repeats of different length, have been described previously (Kazantsev et
al., 1999; Preisinger et al., 1999; Steffan et al., 2000). Exon1 sequences with
25 or 104 glutamines were fused in frame with an enhanced green fluores-
cence protein (GFP) tag at the COOH terminus of each construct (25QP,
104QP). The 47Q construct lacked the proline-rich domain of exon1, and
in addition to the GFP tag on its COOH terminus, had a FLAG tag at-
tached to the NH
 
2
 
 terminus of the huntingtin sequence.
Plasmids encoding either constitutively active or kinase-dead mutant of
FLAG-tagged MEKK1 with deleted NH
 
2
 
-terminal domain, were a gift of
Dr. J. Avruch (Massachusetts General Hospital, Boston, MA). A plasmid
encoding GFP-tagged cistic fibrosis transmembrane conductance regulator
(CFTR) with a point deletion (
 
D
 
F508) was a gift of Dr. R. Kopito (Stanford
University, Stanford, CA). A plasmid encoding GFP-tagged firefly luciferase
was a gift of Dr. R. Day (University of Virginia, Charlottesville, VA). A plas-
mid encoding constitutively active Raf (Raf-CAAX) was a gift of Dr. D.
Stokoe (University of California at San Francisco, San Francisco, CA).
In this study we used antibodies raised against the following: GFP
(polyclonal) (CLONTECH Laboratories, Inc.); FLAG epitope (M2),
 
g
 
-tubulin, and vimentin (Sigma-Aldrich); active-JNK (pTPpY) (Pro-
mega); phospho-p38 (Tyr182) and phospho-p42/44 MAPK (polyclonal)
(New England Biolabs, Inc.); and heat shock proteins Hsp72 (SPA-810)
and Hsp73 (SPA-815) (StressGen Biotechnologies).
 
Cell Cultures and Transfection
 
HeLa human cervical carcinoma cell line, 293 human embryonic kidney
(HEK) cell line, and HN33 rat hippocampal neuronal cell line (received
from Dr. B. Wainer, Emory University, Atlanta, GA) were grown in
DME supplemented with 10% fetal bovine serum at 37
 
8
 
C in an atmo-
sphere of 5% CO
 
2
 
. EcR-293 cell lines expressing huntingtin–GFP fusions
under the control of an inducible promoter have been described previ-
ously (Kazantsev et al., 1999). The expression of an integrated gene of the
NH
 
2
 
-terminal huntingtin fragment containing 300 polyglutamines fused at
the COOH terminus with GFP tag was induced by Muristerone A (Invi-
trogen) according to the manufacturer’s protocol.
For transfection, cells were grown in 35-mm dishes to 25–50% conflu-
ence, and then washed twice with Opti-MEM 1 (Life Technologies). HeLa
cells were transfected for 14–18 h with lipofectamine (Life Technologies)
in accordance with the manufacturer’s protocol, using 3 
 
m
 
l lipofectamine
and 1 
 
m
 
g of DNA (0.8 
 
m
 
g of either 104QP, cistic fibrosis transmembrane
conductance regulator CFTR, or luciferase plasmid, and 0.2 
 
m
 
g of either
MEKK1 plasmid or carrier DNA) per dish. HN33 cells were transfected
under similar conditions with the following modifications: cells were trans-
fected for 10 h with 10 
 
m
 
l of lipofectamine and 2.5 
 
m
 
g of DNA (2.3 
 
m
 
g of
104QP plasmid and 0.2 
 
m
 
g of either MEKK1 plasmid or carrier DNA) per
dish. For an experiment with coexpression of Raf kinase in HeLa cells,
cell culture was transfected for 16 h with GenePORTER™ transfection
reagent (Gene Therapy Systems) in accordance with the manufacturer’s
protocol, using 9 
 
m
 
l of the reagent and 1.5 
 
m
 
g of DNA (0.9 
 
m
 
g of 104QP
plasmid and either 0.6 
 
m
 
g of carrier DNA, or 0.6 
 
m
 
g of Raf plasmid, or 0.2
 
m
 
g of MEKK1 plasmid, and 0.4 
 
m
 
g of carrier DNA) per dish. 293 cells
were transfected for 1.5 h with GenePORTER™ transfection reagent us-
ing 18 
 
m
 
l of the reagent and 3 
 
m
 
g of the plasmid per dish. To end transfec-
tion, the dishes were washed once and left in a regular medium as for the
subsequent treatments and observations described in the text. Efficiency
of transfections was usually in a range of 50–70%.
 
Analysis of IB Formation
 
A Nikon inverted microscope with a 10
 
3
 
 objective was used to observe IB
formation. The number of transfected cells with one or more visible IBs, and 
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the number of transfected cells without IBs were counted independently in
five randomly chosen microscope fields in different areas of a dish. Between
200 and 700 transfected cells were analyzed for each sample. The fractions
of IB-containing cells and 95% confidence interval were calculated.
 
Immunocytochemistry and Confocal Microscopy
 
A Leica TCS 4D laser scanning confocal microscope (MKS Lasertechnik)
with a 40
 
3
 
 oil immersion objective was employed to obtain images of ei-
ther live transfected cells expressing GFP-tagged proteins (FITC only), or
transfected cells after fixation and immunostaining (FITC and TRITC).
For immunostaining, cells on a plastic dish were frozen in liquid nitrogen,
then treated at 
 
2
 
20
 
8
 
C with 100% methanol for 6 min, followed by treat-
ment with a mixture of methanol and acetone (1:1). Thereafter, all proce-
dures were carried out at room temperature. Cells were fixed for 5 min
with 4% formaldehyde in PBS, fixed for 5 min in the same solution with
0.5% Triton X-100, rinsed twice with PBS, and incubated overnight with
primary antibodies. After thorough washing with PBS, samples were incu-
bated for 3–5 h with rhodamine-conjugated secondary antibody, washed
with PBS, and analyzed under the microscope. Primary and secondary an-
tibodies were dissolved in DME supplemented with 50 mg/ml IgG from
nonimmunized animals to reduce nonspecific binding.
 
Preparation of Cell Lysates and Their Analysis
 
Cells were washed twice with PBS on a dish, aspirated, and lysed by thor-
oughly scraping with a plastic scraper in 200 
 
m
 
l lysis buffer per 35-mm dish
(40 mM Hepes, pH 7.5, 50 mM KCl, 1% Triton X-100, 2 mM DTT, 1 mM
Na
 
3
 
VO
 
4
 
, 50 mM 
 
b
 
-glycerophosphate, 50 mM NaF, 5 mM EDTA, 5 mM
EGTA, 1 mM PMSF, 1 mM benzamedine, and 5 
 
m
 
g/ml each of leupeptin,
pepstatin A, and aprotinin). Protein concentration was measured in the ly-
sates, after which they were diluted with lysis buffer to achieve equivalent
protein content in all samples. All procedures were performed at 4
 
8
 
C.
For separation of soluble and insoluble fractions, the lysates were sub-
jected to centrifugation at 400
 
 g
 
 for 10 min The pellets were washed once
with the lysis buffer, and resuspended in a volume of water equal to the
volume of the supernatant. All samples were supplemented with loading
SDS-PAGE buffer containing 2% SDS, and were boiled for 3 min before
being subjected to immunoblotting. GFP-tagged polyQ polypeptides were
visualized with anti-GFP antibody. FLAG-tagged MEKK1 mutants were
visualized with anti-FLAG antibody. A working dilution of 1:1,000 was
used for all primary antibodies except the phospho-JNK antibody
(1:5,000). Secondary antibodies conjugated with peroxidase were visual-
ized with ECL substrates (Amersham Pharmacia Biotech).
In some experiments, the soluble fraction was subjected to further dif-
ferential centrifugation as described in the text. All obtained samples
were treated as described above for the immunoblot analysis.
In some experiments, the soluble fraction was also subjected to gel filtra-
tion on 30-ml Superose 6 FPLC column (Amersham Pharmacia Biotech).
A 200-
 
m
 
l sample was loaded on a column and either 1- or 0.25-ml fractions
were collected, precipitated with 10% TCA, washed once with acetone, and
dissolved in loading SDS-PAGE buffer for immunoblot analysis.
 
In Vitro Measurement of MEKK1 Activity
 
5 
 
m
 
l of either the soluble fraction or the insoluble fraction (resuspended in
an equal volume of lysis buffer) was added to a reaction mixture (25 
 
m
 
l fi-
nal volume) containing (final concentration): 25 mM Hepes, pH 7.5, 1 mM
Na
 
3
 
VO
 
4
 
, 25 mM 
 
b
 
-glycerophosphate, 10 mM MgCl
 
2
 
, 2mM DTT, 15 
 
m
 
M
ATP, 15 
 
m
 
Ci of [
 
g
 
-
 
32
 
P]ATP, and 40 ng of recombinant SEK1-GST. The
reaction was allowed to proceed for 15 min at 30
 
8
 
C and then stopped by
addition of 10 
 
m
 
l of loading SDS-PAGE buffer. Samples were separated
by SDS-PAGE, transferred to nitrocellulose, and exposed to x-ray film.
 
Results
 
Expression of Active MEKK1 Mutant Enhances 
Formation of IBs of Mutant Huntingtin
 
To investigate the possible regulation of IB formation, we
studied intracellular aggregation of NH
 
2
 
-terminal frag-
ment of huntingtin. Exon1 segment of this protein con-
tains a polyQ domain flanked by 17 residues at the NH
 
2
 
terminus and by a proline-rich stretch at its COOH termi-
nus (The Huntington’s Disease Collaborative Research
Group, 1993). We employed an exon1 sequence including
either 25 or 104 glutamine residues, which represent nor-
mal and mutant forms, respectively. COOH termini of
these constructs were fused with the GFP sequences, re-
sulting in 25QP and 104QP polypeptides. When such con-
structs were transiently transfected into mammalian cells,
GFP allowed detection of expression and localization of
the chimerical polypeptides by fluorescent microscopy.
25QP appeared completely soluble, whereas a large frac-
tion of cells expressing 104QP contained bright fluores-
cent IBs (Fig. 1, A and B).
To investigate the effects on protein aggregation of
MEKK1, an important mediator of multiple stress-acti-
vated signaling pathways, HeLa cells were transfected ei-
ther with 104QP alone or together with a plasmid encod-
ing a truncated constitutively active form of MEKK1
(MEKK1
 
D
 
). Introduction of the MEKK1
 
D
 
 led to a large in-
crease in the fraction of cells that form IBs. Indeed, after
16 h of transfection with 104QP alone, the fraction of HeLa
cells that formed one or more IB detectable by the fluores-
cence microscopy was usually far less than
 
 
 
5%, whereas in a
culture cotransfected with active MEKK1 no less than
 
 
 
15–
20% of cells contained IBs. In the course of the next 48 h
the fraction of transfected cells with detectable IBs grew in
both cultures; however, the MEKK1
 
D
 
-dependent increase
in IB formation was sustained (Fig. 2 A). It is noteworthy
that in the course of the experiment, neither expression of
104QP nor coexpression of MEKK1
 
D
 
 caused any signifi-
cant change in viability of the transfected cells (not shown).
Also, MEKK1
 
D
 
 did not cause formation of IBs from the
normal size polyQ domain, 25QP (not shown).
The stimulating effect of MEKK1 on aggregation of
104QP was also observed with the hippocampal HN33 cell
line (Fig. 2 B), as well as with 293, H9c2, and CHO cells
(not shown). Although the control levels of IB formation
observed in these different cell lines varied, expression of
active MEKK1 always led to an increase in IB formation.
To avoid potential artifacts due to simultaneous cotrans-
fection with two different plasmids, we employed the 293
cell line stably transfected with a polyQ-encoding gene un-
der the control of the muristerone-inducible promoter. 293
cells expressed the 300Q–GFP fusion (300Q), which lacks
the proline-rich region of exon1. Our experiments indi-
cated that this region is not critical for either aggrega-
tion of polyQ polypeptides or the stimulatory effect of
MEKK1 on such aggregation (not shown). 300Q was in-
duced with muristerone for 24 h, then cells were tran-
siently transfected with MEKK1
 
D
 
 gene and incubated in
the presence of muristerone for 24 h. Because in this ex-
periment all cells accumulated 300Q but only a few of
them formed IBs, it was technically difficult to count a
fraction of IB-containing cells. Instead, we counted the
number of IBs in five randomly chosen microscopic fields.
The number of cells on a dish and cellular levels of 300Q
were similar in control cultures and cultures expressing
MEKK1
 
D
 
 (not shown). As seen in Fig. 2 C, the expression
of MEKK1
 
D 
 
led to more than a twofold increase in IB for-
mation above levels in the mock-transfected cells. Because
the efficiency of transient transfection under these condi-
tions was 
 
z
 
50% (not shown), MEKK1
 
D
 
 must have been
expressed in only half of the cells, and therefore its effect 
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on IB formation was underestimated by at least twofold in
these experiments.
To test if the stimulation of 104QP aggregation requires
the kinase activity of MEKK1, we investigated if a kinase-
dead mutant of MEKK1 can also stimulate formation
of IBs, when coexpressed with 104QP. In contrast to
MEKK1
 
D
 
, the kinase-dead mutant failed to significantly
stimulate 104QP aggregation (Fig. 3 A, top). Note that the
cellular levels of the kinase-dead mutant were equal to, or
even greater than, the level of MEKK1
 
D
 
 (Fig. 3 A, bot-
tom).
We also tested whether a protein kinase Raf, which reg-
ulates MAPK cascades at the same level as MEKK1
(Cobb and Goldsmith, 1995; Schlesinger et al., 1998), can
similarly stimulate formation of IBs. HeLa cells were
transfected (Materials and Methods) with 104QP expres-
sion vector together with 0.6 
 
m
 
g of activated Raf expres-
sion vector (as a positive control we cotransfected cells
with 0.2 
 
m
 
g of MEKK1
 
D
 
 expression vector). Under these
conditions the expression of activated Raf did not cause a
significant increase in IB formation (Fig. 3 B, top),
whereas cells cotransfected with MEKK1 formed aggre-
gates 2.5–3 times more often than cells expressing just
104QP. Note that expression of active forms of Raf or
MEKK1 led to approximately equal activation of ERK in
transfected cells (Fig. 3 B, bottom).
 
MEKK1 Reduces the Solubility of
Polyglutamine-containing Polypeptides
 
IB formation must involve redistribution of 104QP mole-
cules to the insoluble fraction. Therefore, we studied the
effect of MEKK1 on the solubility of 104QP. HeLa cells
transfected with 104QP were lysed in a buffer containing
Triton X-100, and were then subjected to differential cen-
trifugation. The first centrifugation was for 10 min at
400 
 
g
 
, then the supernatant was centrifuged at 15,000 
 
g
 
 for
10 min, and finally the resulting supernatant was subjected
to centrifugation at 380,000 
 
g
 
 for 40 min. The resulting frac-
tions were dissolved in buffer containing 2% SDS. We
found that 104QP, detected by immunoblotting with anti-
GFP antibody, was present in the lysate in two distinct
fractions: the 400-
 
g
 
 pellets, and the 380,000-
 
g
 
 supernatant
(Fig. 4 A). A similar experiment was done with polyQ of
normal length, and all 25QP were found in the 380,000-
 
g
 
supernatant (not shown). Therefore, the appearance of
polyQ fusion proteins in the particulate fraction correlates
with the tendency to form IBs.
To investigate the formation of IBs, the 104QP-contain-
ing supernatant from the first, low speed centrifugation was
subjected to gel filtration on Superose 6. Surprisingly, al-
most all 104QP migrated as one peak of 
 
z
 
350 kD (Fig. 4
B), which far exceeds the molecular mass of 104QP mono-
mer (
 
z
 
45 kD). These data indicate that soluble 104QP ex-
Figure 1.  Aggregation of 104QP in HeLa cells viewed by confocal microscopy. (A) Cells expressing 25QP construct; (B) cells express-
ing 104QP construct. 
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ists as either a homooligomer of a particular size or a
discrete complex with certain cellular proteins. This obser-
vation suggests that upon IB formation, polyQ polypep-
tides do not generate oligomers of various molecular
masses (distributed over a wide range of fractions rather
than concentrated in one peak). The 25QP were also found
exclusively in a high molecular mass peak (not shown).
We did not observe a change in the elution of the 104QP
peak in the lysates of cells expressing MEKK1
 
D
 
 (not
shown), suggesting that formation of the complex is not
regulated by this kinase. On the other hand, transfection
with MEKK1
 
D
 
 led to a redistribution of 104QP to 400-
 
g
 
pellets (insoluble fraction) (Fig. 5 A, top). Importantly,
transfection with the kinase-dead mutant of MEKK1 did
not significantly affect the solubility of 104QP (Fig. 5 A),
indicating that the kinase activity of MEKK1 is critical for
its stimulation of 104QP redistribution to the insoluble
fraction.
The 104QP found in the 400-
 
g
 
 pellets represents polypep-
tides that are present in IBs and/or associated with large
nonmembranous cellular components, e.g., cytoskeleton
(as cell lysates were prepared in the presence of the deter-
gent, which should dissolve membranous structures). Seem-
ingly, IB formation correlates with redistribution of polyQ
polypeptides to the insoluble fraction: both processes de-
pend on the length of polyQ, they have similar time courses
(not shown), and they are stimulated by MEKK1
 
D
 
.
Surprisingly, in spite of the apparent correlation, stimula-
tion by MEKK1 of redistribution of polyQ polypeptides to
the insoluble fraction could be dissociated from the stimu-
lation of IB formation. This was demonstrated with a fu-
sion polypeptide 47Q consisting of the glutamine-rich part
of huntingtin’s exon1 with 47 glutamines fused to GFP (see
Materials and Methods). As found with 25QP and 104QP,
the soluble 47Q polypeptide (from 400-
 
g
 
 supernatant) mi-
grated as a single peak on a Superose 6 column (not
shown). This polypeptide did not form visible IBs when ex-
pressed in HeLa cells, and cotransfection with MEKK1
 
D
 
did not lead to IB formation (not shown). However,
MEKK1
 
D
 
 expression caused a large increase in the frac-
tion of 47Q associated with 400-
 
g
 
 pellets (multiple bands
on the immunoblot of 47Q in the pellet probably represent
ubiquitinated forms of the polypeptide) (Fig. 5 B). It
should be noted that in cells expressing active MEKK1, a
small fraction of otherwise completely soluble 25QP was
also detected in the pellet (not shown). Therefore, MEKK1
stimulates redistribution of polyQ polypeptides into the in-
soluble fraction, which may or may not result in formation
of visible IBs, depending of the length of polyQ.
 
104QP IBs Colocalize with MEKK1 
in Distinct Cytosolic Structures
 
The fact that MEKK1
 
D
 
 stimulates recruitment of polyQ-
containing polypeptides to the particulate fraction sug-
gests that this kinase may associate with 104QP IB. In-
deed, a large fraction (sometimes 
 
.
 
50%) of MEKK1
 
D
 
 can
be found in 400-
 
g
 
 pellets (Fig. 5 A, bottom). Such associa-
tion of MEKK1
 
D
 
 with the insoluble fraction can be ob-
served both in cells that coexpress 104QP (Fig. 5 A) and
cells that express MEKK1
 
D
 
 alone (not shown), indicating
that the affinity to particulate fractions is an intrinsic trait
Figure 2.  Expression of active MEKK1 mutant stimulates formation of 104QP IBs. (A)
HeLa cells were transfected with 104QP either alone (104QP or Control) or along with
active MEKK1 (1MEKK1). Top, the fractions of transfected cells which form visible IB
were counted at two time points. Bottom, immunoblot shows concentration of soluble
104QP in the same cells at the second time point. (B) HN33 cell line was transfected with
104QP either alone (104QP) or along with active MEKK1 mutant (1MEKK1). The frac-
tions of the transfected cells which form visible IBs, were counted 26 h after start of trans-
fection. (C) 293 cell line stably transfected with the 300Q–GFP fusion under the control
of the muristerone-inducible promoter was incubated with muristerone for 24 h. Cells
were then transfected with either MEKK1D gene (300Q1MEKK1) or carrier DNA alone (300Q) and further incubated in the presence
of muristerone for an additional 24 h. The number of IBs in five randomly chosen microscope fields was counted. 
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of active MEKK1. It is noteworthy that a much lower por-
tion of the kinase-dead mutant, which did not stimulate IB
formation, was found in 400-
 
g
 
 pellets (Fig. 5 A, bottom).
Therefore, the kinase activity appears to be critical for as-
sociation of MEKK1 with the insoluble fraction.
To test whether the MEKK1
 
D
 
 that was associated with
the insoluble fraction was inactive or retained its activity,
we resuspended the pellet in lysis buffer and assayed it
along with the soluble fraction for MEKK1 activity. Puri-
fied recombinant SEK1, MEKK1 substrate, was added to
both fractions, and the ability of MEKK1D to phosphory-
late this protein was tested in the presence of [g-32P]ATP.
Strong phosphorylation of SEK1 was observed in both the
400-g pellet and the supernatant from lysates of cells trans-
fected with MEKK1D (Fig. 6). The apparently lower
MEKK1 activity in the insoluble fraction in compari-
son with the supernatant reflects, most probably, incom-
plete accessibility of MEKK1D to its substrate in the re-
suspended pellet. The assayed activity was specific to
MEKK1, because we did not observe phosphorylation of
SEK1 in the lysates of cells transfected with 104QP alone
(Fig. 6, MEKK1 [2]). Therefore, MEKK1D is active in the
insoluble fraction.
MEKK1 was previously shown to localize at distinct
structures in a cell (Christerson et al., 1999). To study the
role of such structures in formation of 104QP-containing
IBs, we used an immunolocalization approach. FLAG-
tagged MEKK1D was cotransfected with 104QP. Cells
were probed with anti-FLAG antibody and further treated
with a rhodamine-labeled secondary antibody. In accord
with previous reports, MEKK1D was located at discrete
spotted cytosolic structures (Fig. 7 A, red). Such structures
were present even in the cells, which did not form 104QP-
containing IBs, indicating that localization into these
Figure 3.  Stimulation of 104QP IB formation depends on the MEKK1 activity. (A) HeLa cells were transfected with 104QP either
alone (104QP or Control) or along with active MEKK1 mutant (1MEKK1 [act]), or along with kinase-dead MEKK1 mutant
(1MEKK1 [k.d.]). Top, the fractions of transfected cells which form visible IBs were counted at two time points. Bottom, content of
MEKK1 mutants in a soluble fraction of the same cells. Immunoblotting with anti-FLAG antibody. (B) HeLa cells were transfected
with 104QP either alone (104QP or Control) or along with either active MEKK1 mutant (1MEKK1) or active Raf (1Raf) (to increase
the amount of Raf DNA in transfection, it was done differently [see Materials and Methods]). Top, the fractions of transfected cells
which form visible IBs were counted at two time points. Bottom, activation of ERK by transfected MEKK1 or Raf mutants in a soluble
fraction of the same cells. Immunoblotting with anti–phospho-ERK (p42/44 MAPK) antibody.Meriin et al. MEKK1 Stimulates Intracellular Aggregation 857
structures is an intrinsic trait of active MEKK1, indepen-
dent of 104QP. These data are in agreement with the al-
ready mentioned ability of MEKK1D to associate with
insoluble fraction independently of 104QP. Double fluo-
rescence of rhodamine and GFP, detected with confocal
microscopy, showed that all 104QP-containing IBs colo-
calized (Fig. 7 A, yellow) with the structures formed by
MEKK1D, suggesting that MEKK1 may be involved in the
organization of sites of polyQ aggregation.
Similarities and Differences between
Polyglutamine-containing IB and Aggresome
IBs formed by polyQ polypeptides are reminiscent of ag-
gresomes formed by certain abnormal proteins (Johnston
et al., 1998; Garcia-Mata et al., 1999; Wigley et al., 1999).
Therefore, we investigated whether IBs formed with
polyQ polypeptides are indeed similar to aggresomes,
which have been reported to localize to centrosomes, to be
encircled by vimentin filaments, and to contain molecular
chaperones and components of the ubiquitin–proteasome
degradation machinery. To investigate whether the polyQ-
containing IBs are of similar composition and origin, we
again used an immunolocalization approach. Cells trans-
fected with 104QP were immunostained with various anti-
bodies, and further treated with a rhodamine-labeled
secondary antibody. To define the location of the cen-
trosome, we used immunostaining with anti–g-tubulin an-
tibody, the commonly used centrosome marker (Oakley
and Oakley, 1989; Dictenberg et al., 1998). Because the
centrosomes in HeLa cells are diffused and cannot be
clearly detected with anti–g-tubulin antibody (not shown),
we used HEK 293 cells where centrosomes are more con-
densed and could be visualized by immunostaining as de-
scribed previously (Kopito, 1999; Wigley et al., 1999).
Double fluorescence clearly indicated that 104QP IBs
colocalized with g-tubulin–containing structures (Fig. 7 B,
left). As seen in Fig. 7 B, the centrosomes in IB-containing
cells appeared larger than those in cells without IBs, which
is consistent with the prior observation that centrosome
size increases with aggresome formation (Johnston et al.,
1998; Wigley et al., 1999). Furthermore, like aggresomes,
the polyQ-containing IB was surrounded by a network of
vimentin filaments in HeLa cells (Fig. 7 B, right). More-
over, like the aggresome, IBs with 104QP were associated
with both constitutive and inducible members of the
Hsp70 protein family, Hsc73 and Hsp72 (Fig. 7 C).
On the other hand, there is an important difference be-
tween formation of aggresomes and formation of polyQ
IBs, because in HeLa cells the latter process is apparently
independent of microtubules. To test for involvement of
microtubules in the IB formation we employed nocoda-
zole, which disrupts the microtubular network and has
been reported to prevent aggresome formation (Johnston
et al., 1998; Garcia-Mata et al., 1999). HeLa cells trans-
fected with 104QP were either treated for 6 h with 10 mg/
ml of nocodazole or left untreated. Nocodazole treatment
did not block formation of IBs during this time, but rather
potentiated it (Fig. 8). No inhibition of IB formation by
nocodazole was seen either in the presence or absence of
MEKK1D (Fig. 8). Furthermore, nocodazole did not in-
crease the fraction of cells with multiple IBs (not shown).
Similarly, treatment of transfected HeLa cells with 40 mM
cytochalasin B, which disrupts actin filaments, did not
cause any decrease in basal and MEKK1-induced forma-
tion of IBs (Fig. 8). Thus, both basal and MEKK1-stimu-
lated formation of polyQ-containing IBs do not depend on
microtubules and actin filaments in HeLa cells.
Figure 4.  104QP is present in transfected cells in
two distinct forms: supernatant (Sup) and pellet
(Pel). Immunoblots are shown. (A) Differential
centrifugation. HeLa cells were transfected with
104QP either alone (2MEKK1) or along with ac-
tive MEKK1 (1MEKK1). 40 h after the end of
transfection cells were collected, cell lysates were di-
luted to equalize total protein concentration and
subjected to consecutive centrifugations: 10 min at
400 g (0.4K), 10 min at 15,000 g (15K), and 40 min at
380,000 g (380K). (B) Soluble 104QP is present in a
complex of a distinct size. HeLa cells transfected
with the 104QP construct were lysed and subjected
to low speed centrifugation at 400 g for 10 min (Sup
and Pel). The supernatant was loaded onto a Super-
ose 6 FPLC column and gel filtration was performed
in lysis buffer (see Materials and Methods). Frac-
tions were collected (numbering starts upon elution
of a void volume), concentrated by TCA precipita-
tion, and analyzed by immunoblotting. Inset shows
the results of the gel filtration with the four-time de-
creased fraction size.The Journal of Cell Biology, Volume 153, 2001 858
Stressful Treatments Can Stimulate 104QP IB Formation
The fact that MEKK1D is able to stimulate polyQ aggre-
gation leads to an interesting possibility: that the stress-
ful conditions that activate MEKK1 may facilitate forma-
tion of polyQ IBs. In accordance with a previous report
(Wyttenbach et al., 2000), we observed that heat shock
strongly stimulates formation of polyQ-containing IBs
(not shown), but this may be due to a direct denaturing ef-
fect of heat treatment on the polyQ polypeptide. There-
fore, it would be more informative to test for the effect of
MEKK1-activating stresses that do not cause protein dam-
age (e.g., UV irradiation). HeLa cells transiently trans-
fected with 104QP were irradiated with 150 J/m2 UV-C.
As seen in Fig. 9 A, IB formation was strongly increased
by this treatment. Moreover, UV irradiation caused a sig-
nificant redistribution of 104QP into the insoluble fraction
as was seen with transformation of active MEKK1 (Fig. 9
B). Treatment of transfected HeLa cells with a DNA-dam-
aging agent cisplatin, another stimulus known to activate
MEKK1, also stimulated 104QP IB formation (Fig. 9 C).
The stressful stimuli are known to cause apoptosis. In-
deed, a fraction of the cells died as a result of treatment
with either cis-platinum or UV irradiation. There is a possi-
bility that activation of a stress-signaling pathway could
lead to enhanced toxicity of nonaggregated 104QP result-
ing in a cell death and hence in a selective survival of cells
with aggregates. However, this model cannot explain the
stimulation of IB formation by the recombinant active
MEKK1 because, as mentioned above, its coexpression
with 104QP did not cause detectable toxicity. There is also
a possibility that the stimulation of IB formation by the
stressful treatments could result from some late apoptotic
event in dying cells. To address this question, we studied
if stimulation of IB formation by UV irradiation is af-
fected by general caspase inhibitors. The caspase inhibitor
Z-VAD protected cells from apoptosis caused by UV irra-
diation, but did not inhibit the enhancement of aggregation
(not shown). Moreover, continuous exposure of 104QP-
transfected HeLa cells to the caspase inhibitors Z-VAD or
DEVD did not reduce the MEKK1-induced stimulation of
IB formation, indicating that activation of caspases is not
critical for this stimulation. Intriguingly, 104QP aggrega-
tion was greater in the cells with the caspase inhibitors (Fig.
Figure 5.  Expression of active MEKK1 mutant causes associa-
tion of polyQ polypeptides with the insoluble fraction. Trans-
fected HeLa cells were lysed and subjected to low-speed centrifu-
gation at 400 g for 10 min. Immunoblots are shown. Pel(0.4K),
pellet; Sup(0.4K), supernatant. (A) Cells were transfected with
either 104QP alone (2) or along with active MEKK1 mutant
(act.) or along with kinase-dead mutant (k.d.). Samples were col-
lected 30 h after the end of transfection. Top, samples probed
with anti-GFP antibody for 104QP. Bottom, samples probed with
anti-FLAG antibody for MEKK1 mutants. (B) Cells were trans-
fected with either 47Q alone (C) or along with active MEKK1
(M). Samples were collected 25 h after the end of transfection. In
this immunoblot a pellet fraction was resuspended in half of the
original volume.
Figure 6. MEKK1D in insoluble fraction is active. HeLa cells
were transfected with 104QP either alone (2 MEKK1) or along
with active MEKK1 (1MEKK1). 20 h after the end of transfec-
tion cells were collected, and soluble and insoluble fractions were
separated by centrifugations (10 min at 400 g): Sup(0.4K), super-
natant; Pel(0.4K), pellet. Pellets were resuspended in lysis buffer
and both fractions were tested for their ability to phosphorylate
recombinant GST-SEK1. The autoradiogram shows phosphory-
lation of SEK1 in the samples (2GST-SEK1: no substrate was
added to the reaction) (top). The immunoblot with anti-FLAG
antibody shows distribution of FLAG-tagged active MEKK1 be-
tween soluble and insoluble fractions (bottom).Meriin et al. MEKK1 Stimulates Intracellular Aggregation 859
Figure 7.  Colocalization of 104QP IB with active MEKK1 and
cellular proteins. 24 h after the end of transfection HeLa cells were
fixed in a way that mainly retained insoluble structures (Materials
and Methods), including 104QP IB (green, top row). Samples
were probed with antibodies to various proteins (red, middle row)
to study their colocalization (yellow, bottom row) with 104QP.
(A) Anti–g-tubulin and antivimentin antibodies. (B) Anti-FLAG
antibody to localize FLAG-tagged MEKK1 active mutant. (C)
Anti-Hsp73 (constitutive member of the Hsp70 family) and anti-
Hsp72 (inducible member of the Hsp70 family) antibodies.The Journal of Cell Biology, Volume 153, 2001 860
9 D). This stimulatory effect was seen both in the presence
and in the absence of MEKK1, suggesting that there is a
caspase-regulated pathway influencing IB formation.
MEKK1 may exert its action on polyQ aggregation via
stimulation of one of the stress-activated signaling path-
ways. Indeed, it is well documented that MEKK1 may ac-
tivate JNK, p38, and ERK/ MAP-related kinases (Kyriakis
and Avruch, 1996; Schlesinger et al., 1998). There are also
reports that this kinase is a potential activator of NF-kB
(Lee et al., 1997, 1998). However, it appears that none of
these pathways is involved in MEKK1D-induced stimula-
tion of polyQ aggregation. Indeed, with 293 cells, where
MEKK1D expression activated cellular JNK, p38, or ERK,
their active forms did not associate with the insoluble frac-
tion, in contrast to MEKK1 (not shown). Furthermore,
pharmaceutical inhibitors of either ERK (U0126), p38
(SB203580), or NF-kB (aspirin) pathways did not signifi-
cantly reduce MEKK1D-stimulated formation of 104QP-
containing IBs (not shown). Moreover, in the HeLa cell
line chosen for this study while stimulating IB formation,
expression of MEKK1D did not cause any detectable acti-
vation of JNK (not shown). These data suggest that either
MEKK1 directly phosphorylates and activates a compo-
nent necessary for IB formation, or it acts via a yet un-
known signaling pathway.
MEKK1 Stimulates Aggregation of Various Proteins
How general is the ability of MEKK1 to stimulate IB for-
mation? To address this question we studied the influence
of this kinase on the aggregation of a polypeptide, which
lacks a polyQ domain, a CFTR. The ability of this protein
to fold properly is drastically reduced by deletion of a sin-
gle amino acid (F508), which leads to its rapid protea-
some-dependent degradation. If degradation is blocked by
a proteasome inhibitor, this polypeptide accumulates and
forms an aggresome (Johnston et al., 1998). Transient
transfection of HeLa cells with a gene of CFTR fused to
GFP led to its accumulation at a very low level in a small
fraction of cells. The fluorescence was homogeneous and
no IBs were seen (Fig. 10, top, Control). Overnight incu-
bation of transfected cells in the presence of 5 mM of the
proteasome inhibitor MG132 strongly increased accumu-
lation of CFTR. In a large fraction of fluorescent cells IBs
were clearly detectable (Fig. 10, top, MG132). In contrast
to polyQ-containing IBs, these IBs were less compressed
and often formed a crescent-shaped structure surrounding
the nucleus. Cotransfection of CFTR cells with MEKK1D
had an effect similar to that of inhibition of the protea-
some activity, i.e., the number of fluorescent cells detect-
able under a microscope increased, and in most of them
IB-like structures were formed (Fig. 10, top, MEKK1).
We also investigated aggregation of a firefly luciferase.
This protein is normally soluble, but easily aggregates in
cells exposed to heat shock (Michels et al., 1995). To test
for the effect of MEKK1D on luciferase aggregation we
employed a GFP–luciferase fusion protein (Day et al.,
1998). When transiently expressed in HeLa cells, this fu-
sion polypeptide does not aggregate (Fig. 10, bottom, Con-
trol) except in some dead cells (Fig. 10, bottom, Dead
cell). Heat shock of cells at 448C for 30 min followed by a
15-h recovery period led to appearance of luciferase IBs in
living cells (Fig. 10, bottom, Heat Shock). To our surprise,
cotransfection with MEKK1 also led to aggregation of lu-
ciferase without any additional stress (Fig. 10, bottom,
MEKK1). These data demonstrate that the effect of
MEKK1 on IB formation is not limited to proteins with
polyQ extensions.
Discussion
Here we demonstrate that formation of IBs by polyQ-con-
taining polypeptides as well as other abnormal proteins is
regulated by MEKK1, a kinase that activates several stress
kinase cascades. This finding is unexpected, as protein ag-
gregation in a cell has been viewed as a spontaneous, en-
ergy-independent process that could easily be observed in
a test tube with a solution of purified protein. For the same
reasons, protein folding was previously viewed as a spon-
taneous, energy-independent process until it became evi-
dent that cells have a very complicated chaperone machin-
ery to facilitate proper folding, which may consume
hundreds of ATP molecules per one folded polypeptide
chain (Horwich et al., 1999; Agashe and Hartl, 2000; Feld-
man and Frydman, 2000). Similarly, it appears that protein
aggregation in the cell is an active process that involves
cellular components. Some features of this process have
already been described for several abnormal polypeptides,
including specific localization of protein inclusions at the
centrosome in the cytosol (Anton et al., 1999; Garcia-Mata
et al., 1999; Vidair et al., 1999; Wigley et al., 1999; Fabunmi
et al., 2000) or promyelocytic leukemia oncogenic domains
Figure 8.  Disruption of microtubules or actin filaments does
not abrogate stimulation of 104QP IB formation by MEKK1.
HeLa cells were transfected with 104QP construct either alone
(104QP) or along with active MEKK1 (104QP1MEKK1). After
the end of transfection some cells were treated with 10 mg/ml of
nocodazole (Noc) to disrupt microtubules, or with 40 mM cyto-
chalasin B (Cyt) to disrupt actin filaments. The fractions of trans-
fected cells which form visible IBs were counted either before or
6 h after the start of treatments.Meriin et al. MEKK1 Stimulates Intracellular Aggregation 861
in the nucleus (Anton et al., 1999), microtubule-dependent
transport of microaggregates to the centrosome (Johnston
et al., 1998; Garcia-Mata et al., 1999), and recruitment of
chaperones and components of the ubiquitin–proteasome
pathway (Anton et al., 1999; Garcia-Mata et al., 1999; Vid-
air et al., 1999; Wigley et al., 1999; Fabunmi et al., 2000).
Our findings indicate that protein aggregation in a cell is a
regulated process.
Enhancement of aggregate formation by MEKK1 sug-
gests that protein aggregation may be regulated by stressful
stimuli. Many stressful treatments, e.g., heat shock and oxi-
dative stress, cause protein damage. Therefore, enhance-
ment of protein aggregation by these stresses, which has
been well documented (Kampinga, 1993; Kabakov and
Gabai, 1994), could be explained by direct effects on un-
folding of the aggregated polypeptides. The novel possibil-
ity is that activation of stress-signaling pathways may also
contribute to the stimulation of aggregation by protein-
damaging stresses. Furthermore, we demonstrated here
that stresses that do not cause direct protein damage (e.g.,
DNA-damaging agents, UV irradiation) can also enhance
aggregation of a polyQ-containing protein, probably via ac-
tivating MEKK1. Unfortunately, technically it was not fea-
sible to directly test the possibility that MEKK1 is essential
Figure 9.  Stresses and caspase inhibitors stimulate aggregation
of 104QP. HeLa cells were transfected with 104QP either alone
(104QP or C) or along with active MEKK1 (104QP 1 MEKK1 or
M). (A) Cells after transfection were either UV-irradiated (150 J/m2)
104QP/UV or left untreated and the fractions of transfected cells
which form visible IB, were counted at two time points. (B) Immu-
noblot of soluble supernatant (Sup[0.4K]) and insoluble pellet
(Pel[0.4K]) fractions of the same (see Fig. 9 A) transfected cells
collected at the second time point. (C) Cells after transfection
were either exposed for 12 h to 40 mM cisplatin (104QP/cisPl) or
left untreated and the fractions of transfected cells which form vis-
ible IBs were counted. (D) Cells marked 104QP/ZVAD from the
start of transfection were exposed to 100 mM ZVAD and the frac-
tions of transfected cells which form visible IBs were counted 17 h after the start. Cells marked 104QP/DEVD from the start of transfec-
tion were exposed to 100 mM DEVD and the fractions of transfected cells which form visible IBs were counted 21 h after the start.The Journal of Cell Biology, Volume 153, 2001 862
for this stimulation of aggregation, because the kinase-
dead mutant of this kinase did not manifest a sufficient in-
hibitory effect. The observed potentiation of IB formation
by nocodazole and cytochalasin B (Fig. 8) may also result
from activation of stress signaling by these agents.
There are several possible reasons why a mechanism for
regulation of protein aggregation by a stress-activated
signaling pathway has evolved. Abnormal proteins that
emerge in the cell due to mutations, chemical modifica-
tions, or stress-induced denaturation may either be re-
folded by chaperones or degraded via the ubiquitin–pro-
teasome pathway. If these processes are not efficient
enough and abnormal proteins accumulate, they become
toxic. Under these conditions forced protein aggregation
leading to IB formation may become an efficient mecha-
nism to rapidly reduce the levels of the unfolded mole-
cules in the soluble phase, thus representing a cellular
defense mechanism to segregate and limit the toxic con-
sequences of the abnormal proteins. On the other hand,
if IBs are involved in initiation of an apoptotic pro-
gram, the regulated formation of IBs may serve to elimi-
nate potentially damaged cells. Obviously, accumulation
of abnormal polypeptides is most likely to occur under
stressful conditions, and therefore it is reasonable that this
process is upregulated by a stress-activated protein kinase
MEKK1. The stress-regulated formation of IBs may be es-
pecially relevant to neurons in disease. As mentioned in
the Introduction, such cells may experience an internal
stress and stimulation of stress-activated signaling path-
ways. Therefore, MEKK1-mediated stimulation of forma-
tion of IBs may be an adaptive mechanism designed to re-
duce neurodegeneration by protecting from apoptosis, or
eliminating defective neurons.
As reported previously, in contrast to other members of
this protein kinase family, MEKK1 associates with dis-
crete spotted cellular structures (Christerson et al., 1999).
We confirmed this observation (Fig. 7 A) and found that a
large fraction of the overexpressed MEKK1 mutant asso-
ciates with the 400 g pellets while retaining its activity. In
contrast, a much lower fraction of inactive MEKK1 mu-
tant associated with this fraction (Fig. 5 A). Furthermore,
when coexpressed, 104QP IB colocalized with one or sev-
eral of MEKK1-containing structures. These data suggest
that MEKK1 may play a direct role in formation of an IB.
We could not detect direct association of MEKK1 with
soluble 104QP by coimmunoprecipitation (not shown).
We were also unable to observe any change of the size of
soluble 104QP complex in response to expression of active
MEKK1. These data suggest that MEKK1D does not di-
rectly interact with soluble 104QP. Rather, as discussed
below, it seems to activate the nucleation process. One of
the possibilities is that MEKK1 associates with a compo-
nent of the cytoskeleton and facilitates an IB seeding
event by phosphorylation of a factor, which triggers the IB
nucleation. We were unable to observe involvement of
known MEKK1-activated pathways in aggregation of
polyQ. Also, we found that the activated form of Raf, an-
other kinase that stimulates MAPK cascades, was not
competent in stimulation of 104QP aggregation when co-
expressed with this polypeptide. Therefore, it seems either
that MEKK1 can directly activate the aggregation process,
or that there is a distinct, yet unknown signaling pathway
activated by this kinase.
In this work we also investigated basic events in forma-
tion of an IB by a polyQ-containing polypeptide. There
was an unexpected finding that 104QP did not form multi-
ple homooligomers in the process of aggregation. This
molecule was only found in a soluble form in a discrete
complex of z350 kD, or in very large structures precipi-
tated at 400 g, most likely associated with components of
Figure 10.  MEKK1 stimulates aggregation of proteins lacking
polyQ domain. Confocal microscopy. Top, HeLa cells were
transfected with GFP-tagged CFTR either alone (Control or
MG132) or along with active MEKK1 mutant (MEKK1). After
transfection one sample transfected with CFTR alone was incu-
bated with 5 mM of proteasome inhibitor MG132 for 15 h
(MG132). Bottom, HeLa cells were transfected with GFP-tagged
luciferase either along with active MEKK1 mutant (MEKK1) or
alone (all other pictures). Cells transfected with luciferase alone
after transfection were either left untreated (Control [living
cells], and Dead cell) or heated at 448C for 30 min followed by
15-h recovery (Heat Shock).Meriin et al. MEKK1 Stimulates Intracellular Aggregation 863
the cytoskeleton. We found that polyQ-containing IBs
have certain similarities with aggresomes, but also impor-
tant differences. Like aggresomes, the IBs localized to the
centrosome were surrounded by intermediate filaments,
and recruited major chaperones. On the other hand, IB
formation was not inhibited by nocodazole or cytochala-
sin, and therefore did not require either microtubules or
actin filaments, at least in HeLa cells. This finding is in
striking contrast to aggresome formation, which involves
transport of microaggregates along the microtubules.
Based on these findings, we propose that formation of
IBs by polyQ polypeptides involves a nucleation step, fol-
lowed by growth of an IB because of direct association of
soluble 104QP complexes with a seed (a “snowball” mech-
anism). 104QP nucleation appears to be the only rate-lim-
iting step because once an aggregation seed emerges, all
the polypeptides in a cell aggregate within ,20 min (Ka-
zantsev, A., unpublished). Hence, MEKK1 is likely to fa-
cilitate only the nucleation of polyQ. Because large IBs
are found associated with the centrosome, it is likely that
MEKK1-initiated nucleation sites are preferably formed
within the centrosome. On the other hand, multiple IBs
are seen in a fraction of cells. Therefore, it appears that
several minor nucleation sites could also be formed at
other locations in the cytosol as well. Even if nucleation is
initiated at multiple sites in a cell, 104QP may still form a
single IB because once the first nucleation site emerges, all
the soluble 104QP will rapidly aggregate, and the other
nucleation sites would not play a role. However, they may
become important for the less aggregation-prone 47Q. For
this polypeptide, whereas the nucleation step is still rate
limiting, the growth of an IB is probably a slow and revers-
ible process. Slow aggregation of 47Q at multiple sites may
lead to its inability to form an IB large enough to become
visible under the microscope. Interestingly, when growth
of 104QP-containing IB is artificially inhibited, one can
observe appearance of multiple small “seeds” in a cell
(Kazantsev, A., unpublished). It is noteworthy that minor
nucleation sites may become especially important in very
extended neuronal cells. In fact, in such cells visible aggre-
gates were observed not only in the cell body where the
centrosome is located, but also in the axon (Li et al., 1999).
It is possible that in neurons the preformed aggregates
may be transported to a centrosome via microtubules.
The effects of MEKK1 on protein aggregation are not
limited to the polyQ-containing proteins. Indeed, MEKK1
was able to facilitate aggregation of CFTR and luciferase.
CFTR was the first polypeptide to be shown to form an ag-
gresome (Johnston et al., 1998). In HeLa cells we did not
see association of CFTR with a single spot-like body, but
rather with the crescent-like structure in close proximity to
a nucleus (Fig. 10), suggesting that the appearance of ag-
gresomes may vary depending on cell type and other fac-
tors. Activation of CFTR aggregation by MEKK1, as well
as by proteasome inhibitors, was associated with accumu-
lation of this polypeptide. The effect of the proteasome in-
hibitors was attributed to stabilization of a short-lived
CFTR, leading to formation of IBs. It is unlikely that
MEKK1 also stimulates CFTR aggregation through regu-
lation of its degradation. Rather, MEKK1 enhances aggre-
gation, which may render CFTR less susceptible to the
degradation machinery, resulting in accumulation of this
polypeptide in IB. Although these alternatives cannot be
dissected experimentally, the fact that MEKK1 was able to
facilitate aggregation of relatively stable (not shown)
polyQ polypeptides, is in line with the latter scenario. It is
noteworthy that proteasome inhibitors activate stress sig-
naling pathways (Meriin et al., 1998), including MEKK1
(Meriin, A.B., unpublished data). Therefore, MEKK1 ac-
tivity may contribute to the stimulation of protein aggre-
gation by proteasome inhibitors.
The most intriguing finding is how MEKK1 enhances
aggregation of luciferase, which does not aggregate spon-
taneously. The fact that luciferase aggregates when cells
are exposed to mild heat shock suggests that the luciferase
conformation can easily be destabilized. There is probably
a constant process of unfolding and refolding of luciferase
at normal temperature but because of the lack of nucle-
ation no aggregates are formed. MEKK1 may facilitate
creation of nucleation sites, which would lead to capturing
unfolded molecules at these sites and to shifting the equi-
librium towards aggregation.
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